<DOC>
	<DOCNO>NCT00350428</DOCNO>
	<brief_summary>This randomise controlled clinical trial compare laser peripheral iridotomy ( LPI ) primary phacoemulsification intra-ocular lens implantation ( phaco/IOL ) treatment acute primary angle-closure glaucoma ( APACG ) . Following successful medical lowering raise intra-ocular pressure ( IOP ) control intraocular inflammation , patient present Singapore National Eye Centre Singapore General Hospital acute primary angle-closure glaucoma meet eligibility randomise one two treatment arm : laser peripheral iridotomy primary phacoemulsification intra-ocular lens implantation . These patient monitor closely 2 year post-operatively .</brief_summary>
	<brief_title>Laser Iridotomy Versus Phacoemulsification Acute Angle Closure</brief_title>
	<detailed_description>AIMS The objective study conduct randomise controlled clinical trial compare LPI primary phacol/IOL treatment APACG . The specific aim compare long-term IOP control patient undergo LPI patient undergo primary phaco/IOL . At time follow study . 1 . To evaluate safety two technique treatment APACG 2 . To assess development PAS 3 . To establish LPI primary phaco/IOL effective prevent recurrence acute attack eye APACG TREATMENT PLAN Initial Medical Treatment Patients APACG treat initially acute attack medical treatment . The initial treatment standardize following : 1 . Intravenous acetazolamide ( Diamox ) 500 mg stat 2 . Oral acetazolamide 250 mg tid qid Span K 1.2 g om 3 . Topical beta-blocker ( Timolol 0.5 % ) bid Brimonidine bid beta-blockers contra-indicated . 4 . Topical pilocarpine 4 % qid 5 . Topical steroid 6 . Intravenous mannitol 20 % 1-2g/kg 4 hour initiation treatment IOP reduce 20 % initial IOP unless contra-indicated due systemic disease eg . Congestive heart failure . 7 . A second infusion intravenous mannitol 20 % 2g/kg 12 hour initiation treatment IOP still reduce 20 % initial IOP Response Initial Treatment Evaluation Cataract Patients divide 2 category base IOP 24 hour initiation medical treatment : ( ) APACG IOP £ 30 mmHg ( b ) APACG IOP &gt; 30 mmHg . Patients IOP £ 30 mmHg evaluate clinically presence cataract divide cataract without cataract . Patients cataract defined best correct visual acuity equal le 6/15 due lens opacity opinion consultant grade ophthalmologist . Note : Eyes intumescent cataract ( phacomorphic glaucoma ) , subluxate lens anterior chamber depth differ 0.3 mm exclude . Eligible patient informed consent randomise . Laser Peripheral Iridotomy 1 . In addition consultant , LPI may perform registrar , senior registrar fellows observed taught glaucoma consultant deem able perform procedure high standard . 2 . LPI perform cornea sufficiently clear ( usually within 72 hour ) follow lower IOP medically . 3 . Technique LPI standardize sequential argon-Nd-YAG Laser PI . 4 . LPI sit superior nasal superior temporal quadrant . 5 . The size open ³ 200mm . 6 . Following successful LPI , topical eyedrop continue one week procedure . Oral Diamox discontinue . 7 . If initial attempt unsuccessful , LPI second alternative site attempt . If second attempt remain unsuccessful , patient consider failure . Phacoemulsification Intra-ocular Lens Implantation 1 . All phacoemulsification intraocular lens implantation perform consultant surgeon . The panel surgeon form group co-investigators study . 2 . Phacoemulsification carry 5 7 day follow lower IOP . This allow improve corneal clarity reduction intra-ocular inflammation . 3 . Gutt pilocarpine stop morning operation . 4 . Pre-operative intravenous mannitol 20 % 1-2g/kg give 2 hour start operation subject IOP persistently raise 21mmHg . 5 . Clear corneal incision . 6 . Viscoelastic agent inject 360 degree circumferentially angle deepen anterior chamber . There angle augmentation procedure use surgical instrument . 7 . A standard foldable IOL ( Type IOL : Acrysof MA60 ) 8 . Viscoelastic agent remove end operation far possible . 9 . Oral Diamox 250 mg give stat post-operatively reduce post-operative IOP spike . 10 . Following successful phacoemulsification IOL implantation , topical steroid antibiotic give . Topical pilocarpine , timolol oral Diamox stop . IOP Lowering Medication With regard determination endpoint IOP evaluation consider post-operative week 3 onward . This allow treatment short-term surgery relate IOP fluctuation . During follow period , rise IOP occur , i.e . IOP 22 24 mmHg two occasion within one month IOP ³ 25 mmHg one occasion , IOP lower medication start . FOLLOW-UP Post operation visit Window period 1st week ± 2 day 3rd week ± 5 day 6th week ± 7 day 3rd month ± 2 week 6th month 2nd year ± 3 week At completion trial patient receive normal clinical follow 4-6 monthly thereafter whilst data collect study . The primary objective study compare IOP control two treatment group . STATISTICAL CONSIDERATIONS Sample Size Calculation : The primary objective study compare long-term intra-ocular pressure ( IOP ) control two group . The proportion subject whose IOP successfully control LPI group estimate 60 % ( Aung T 2001 ) . And proportion subject whose IOP successfully control phacoemulsification intra-ocular lens implant group 20 % clinical estimation . Hence , study need sample size 70 patient ( Machin , Campbell , Fayers &amp; Pinol , 1997 ) , 35 group . This sufficient detect 60 % vs. 20 % proportion subject develop increase IOP two group two-sided test power 90 % significance level control 5 % . Statistical Analysis Plan All statistical analysis carry intention-to-treat basis . In event lose follow-up , patient still include analysis duration observe , last IOP assess lose follow-up use data analysis . To compare long-term IOP control two treatment , Pearson χ2 test Fisher ’ exact test use . The evaluation incidence recurrence acute attack eye APACG carry use Fisher ’ exact test . Logistic regression carry adjust relevant covariates . The time interval subsequent increase IOP occur LPI phacol/IOL record . Kaplan-Meier life table analysis apply assess survival time ( failure define need glaucoma treatment ) two group , Log rank test use compare two survival curve . In addition , The Cox regression use adjust covariates applicable . An interim statistical analysis carry patient complete 6 month follow-up . REFERENCES 1 . Acton J , Salmon JF , Scholtz R. Extracapsular cataract extraction posterior chamber lens implantation primary angle-closure glaucoma . J Cataract Refract Surg . 1997 Jul-Aug ; 23 ( 6 ) :930-4 . 2 . Aung T , Ang LP , Chan SP , Chew PT . Acute primary angle-closure : long-term intraocular pressure outcome Asian eye . Am J Ophthalmol . 2001 ; 131 ( 1 ) :7-12 . 3 . Chylack LTJ , Wolfe JK , Singer DM , et al . The Lens Opacities Classification System III . Arch Ophthalmol 1993 ; 111:831-836 . 4 . Fleiss JL . Statistical method rate proportion . New York : Wiley , 1981:2nd edition . 5 . Greve EL Primary angle closure glaucoma : extracapsular cataract extraction filter procedure ? Int Ophthalmol . 1988 ; 12 ( 3 ) :157-62 . 6 . Gunning FP , Greve EL . Uncontrolled primary angle closure glaucoma : result early intercapsular cataract extraction posterior chamber lens implantation . Int Ophthalmol . 1991 Jul ; 15 ( 4 ) :237-47 . 7 . Gunning FP , Greve EL . Lens extraction uncontrolled angle-closure glaucoma : long-term follow-up . J Cataract Refract Surg . 1998 Oct ; 24 ( 10 ) :1347-56 . 8 . Ho T , Fan R. Sequential argon-Yag laser iridotomy dark iris . Br J Ophthalmol 1992 ; 76:329 –331 . 9 . Hoffer KJ . Axial dimension human cataractous lens . Arch Ophthalmol 1993 ; 111 ( 7 ) :914-8 . 10 . Hong C , Kitazawa Y , Tanishima H. Influence argon laser treatment glaucoma corneal endothelium . Japan J Ophthalmol 1983 ; 27 ( 4 ) :567-74 . 11 . Ishikawa H , Ritch R , Liebmann J. Quantitative assessment anterior segment use Ultrasound Biomicroscopy . Current Opinions In Ophthalmology . 2000 ; 11:133-139 . 12 . Lim L , Seah SKL , Lim ASM . Comparison argon laser iridotomy sequential argon laser Nd : YAG laser iridotomy dark iris . Ophthalmic surgery laser 1996 ; 27 ( 4 ) :92-95 . 13 . Lowe RF . Aetiology anatomical basis primary angle-closure glaucoma : biometrical comparison normal eye eye primary angle-closure glaucoma . Br J Ophthalmol 1970 ; 54 ( 3 ) :161-9 . 14 . Lowe RF : Primary angle-closure glaucoma : review ocular biometry , Aust NZ J Ophthalmol 1977 ; 5:9 . 15 . Lowe RF . Clinical type primary angle-closure glaucoma . Aust NZ J Ophthalmol 1988 ; 16:245-50 . 16 . Obstbaum SA . Glaucoma intraocular lens implantation . J Cataract Refract Surg 1986 ; 12:257-61 . 17 . Pavlin , CJ , Foster , FS . Ultrasound biomicroscopy glaucoma . [ Review ] . Acta Ophthalmologica - Supplement . 1992 ; 7-9 . 18 . Roberts TV , Francis IC , Lertusumitkul S , Kappagoda MB , Coroneo MT . Primary phacoemulsification uncontrolled angle-closure glaucoma . J Cataract Refract Surg 2000 ; 26:1012-16 . 19 . Teekhasaenee C , Ritch R. Combined phacoemulsification goniosynechialysis uncontrolled chronic angle-closure glaucoma acute angle-closure glaucoma . Ophthalmology . 1999 Apr ; 106 ( 4 ) :669-74 . 20 . Wishart PK , Atkinson PL . Extracapsular cataract extraction posterior chamber lens implantation patient primary chronic angle-closure glaucoma : effect intraocular pressure control . Eye . 1989 ; 3 ( Pt 6 ) :706-12 .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Angle-Closure</mesh_term>
	<criteria>1 . APACG . In case eye eligible , right eye enter . 2 . IOP le equal 30 mmHg within 24 hour presentation initiation medical treatment 3 . Significant cataract best correct visual acuity equal le 6/15 4 . Informed consent 1 . Secondary cause angleclosure e.g . subluxed lens , uveitis , trauma neovascular glaucoma 2 . Intumescent cataract ( phacomorphic glaucoma ) 3 . Eyes anterior chamber depth differ 0.3 mm 4 . Eyes cataract 5 . Active ocular infection either eye would prevent surgery 6 . Female subject pregnant , nurse childbearing potential use adequate contraception 7 . Participating another study 8 . Previous intraocular eye surgery affect eye . 9 . Any medical condition would contraindication surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Acute primary angle closure</keyword>
	<keyword>Laser preipheral iridotomy</keyword>
	<keyword>Phacoemulsification</keyword>
</DOC>